Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials

Critical Care Medicine

Volumn 39, Issue 3, 2011, Pages 554-559

  Kamel, Hooman ^a   Navi, Babak B ^a   Nakagawa, Kazuma ^a   Hemphill, J Claude ^a   Ko, Nerissa U ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hypertonic saline; intracranial hypertension; intracranial pressure; mannitol; meta analysis; randomized controlled trial

Indexed keywords

MANNITOL; SODIUM CHLORIDE;

ARTICLE; BIBLIOGRAPHIC DATABASE; BRAIN HEMORRHAGE; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA COLLECTION METHOD; EMBASE; HUMAN; INTRACRANIAL PRESSURE; MEDLINE; META ANALYSIS; PRESSURE MEASUREMENT; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

EID: 79952189224     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206b9be     Document Type: Review

References (47)

1. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al: Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma 2007; 24:S14-S20.
2. Broderick J, Connolly S, Feldmann E, et al: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007; 116: e391-e413.
3. Adams HP Jr, del Zoppo G, Alberts MJ, et al: Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:1655-1711. (Pubitemid 46691097)
4. Bederson JB, Connolly ES Jr, Batjer HH, et al: Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40:994-1025.
5. Stravitz RT, Kramer AH, Davern T, et al: Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35:2498-2508. (Pubitemid 351339009)
6. Diringer MN, Zazulia AR: Osmotic therapy: Fact and fiction. Neurocrit Care 2004; 1:219-233. (Pubitemid 41278371)
7. Schwartz ML, Tator CH, Rowed DW, et al: The University of Toronto head injury treatment study: A prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984; 11:434-440. (Pubitemid 15222695)
8. Oken DE: Renal and extrarenal considerations in high-dose mannitol therapy. Ren Fail 1994; 16:147-159. (Pubitemid 24341121)
9. Bentsen G, Breivik H, Lundar T, et al: Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: A prospective clinical trial in critically ill patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand 2004; 48: 1089-1095. (Pubitemid 39274124)
10. Bentsen G, Breivik H, Lundar T, et al: Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med 2006; 34:2912-2917. (Pubitemid 44808731)
11. White H, Cook D, Venkatesh B: The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg 2006; 102:1836-1846. (Pubitemid 43799864)
12. Forsyth LL, Liu-DeRyke X, Parker D Jr, et al: Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury. Pharmacotherapy 2008; 28:469-484. (Pubitemid 351466459)
13. Schwarz S, Schwab S, Bertram M, et al: Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998; 29:1550-1555. (Pubitemid 28365572)
14. Battison C, Andrews PJ, Graham C, et al: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/ 6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005; 33:196 -202; discussion 257-298. (Pubitemid 40116557)
15. Vialet R, Albanèse J, Thomachot L, et al: Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003; 31:1683-1687. (Pubitemid 36714221)
16. Harutjunyan L, Holz C, Rieger A, et al: Effi- ciency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients-A randomized clinical trial [ISRCTN62699180]. Crit Care 2005; 9:R530-R540.
17. Ichai C, Armando G, Orban JC, et al: Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med 2009; 35:471-479.
18. Francony G, Fauvage B, Falcon D, et al: Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36: 795-800.
19. Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of metaanalyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900.
20. Cook DJ, Guyatt GH, Ryan G, et al: Should unpublished data be included in metaanalyses? Current convictions and controversies. JAMA 1993; 269:2749-2753. (Pubitemid 23154248)
21. Lefebvre C, Manheimer E, Glanville J: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Interventions, version 5. 0.2. Higgins JPT, Greene S (Eds). Available at: http://www.cochranehandbook. org. Accessed April 26, 2010.
22. Higgins J, Altman D: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2. Higgins JPT, Greene S (Eds). Available at: http://www.cochrane-handbook.org. Accessed April 26, 2010.
23. Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5:13.
24. Higgins J, Deeks J: Selecting studies and collecting data. In: Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2. Higgins JPT, Greene S (Eds). Available at: http://www.cochrane-handbook.org. Accessed April 26, 2010.
25. Furukawa TA, Barbui C, Cipriani A, et al: Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 2006; 59:7-10. (Pubitemid 41797469)
26. Deeks J, Higgins J, Altman D: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2. Higgins JPT, Greene S (Eds). Available at: http://www. cochrane-handbook.org. Accessed April 26, 2010.
27. Afifi W, Abdallah I, Yosry M, et al: The effect of a single dose of 3% hypertonic saline versus mannitol 20% for treatment of brain oedema and intracranial hypertension in postoperative patients with supratentorial gliomata. Egyptian J Anaesthesia 2003; 19: 371-379. (Pubitemid 37369830)
28. Schatzmann C, Heissler HE, König K, et al: Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients. Acta Neurochir Suppl 1998; 71:31-33. (Pubitemid 128444348)
29. Suarez JI, Qureshi AI, Bhardwaj A, et al: Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998; 26:1118-1122. (Pubitemid 28272866)
30. Horn P, Mü nch E, Vajkoczy P, et al: Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res 1999; 21:758-764.
31. Schwarz S, Georgiadis D, Aschoff A, et al: Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002; 33:136-140. (Pubitemid 34055759)
32. Koenig MA, Bryan M, Lewin JL III, et al: Reversal of transtentorial herniation with hypertonic saline. Neurol 2008; 70:1023-1029. (Pubitemid 351451321)
33. Oddo M, Levine JM, Frangos S, et al: Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry 2009; 80:916-920.
34. Kerwin AJ, Schinco MA, Tepas JJ III, et al: The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: A pilot study. J Trauma 2009; 67: 277-282.
35. Ware ML, Nemani VM, Meeker M, et al: Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: A preliminary study. Neurosurg 2005; 57:727-736.
36. Paczynski RP: Osmotherapy. Basic concepts and controversies. Crit Care Clin 1997; 13: 105-129.
37. Muizelaar JP, Lutz HA III, Becker DP: Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 1984; 61: 700-706. (Pubitemid 14000601)
38. Burke AM, Quest DO, Chien S, et al: The effects of mannitol on blood viscosity. J Neurosurg 1981; 55:550-553. (Pubitemid 12227586)
39. Mendelow AD, Teasdale GM, Russell T, et al: Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 1985; 63:43-48. (Pubitemid 15067271)
40. Donato T, Shapira Y, Artru A, et al: Effect of mannitol on cerebrospinal fluid dynamics and brain tissue edema. Anesth Analg 1994; 78:58-66. (Pubitemid 24012602)
41. Alvarez B, Ferrer-Sueta G, Radi R: Slowing of peroxynitrite decomposition in the presence of mannitol and ethanol. Free Radic Biol Med 1998; 24:1331-1337. (Pubitemid 28246750)
42. Korenkov AI, Pahnke J, Frei K, et al: Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia. Neurosurg Rev 2000; 23:145-150.
43. Cooper DJ, Myles PS, McDermott FT, et al: Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: A randomized controlled trial. JAMA 2004; 291:1350-1357. (Pubitemid 38541650)
44. Murphy N, Auzinger G, Bernel W, et al: The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39: 464-470. (Pubitemid 38222187)
45. Rozet I, Tontisirin N, Muangman S, et al: Effect of equiosmolar solutions of mannitol versus hypertonic saline on intraoperative brain relaxation and electrolyte balance. Anesthesiology 2007; 107:697-704. (Pubitemid 351325960)
46. Wu CT, Chen LC, Kuo CP, et al: A comparison of 3% hypertonic saline and mannitol for brain relaxation during elective supratentorial brain tumor surgery. Anesth Analg 110:903-907.
47. Gemma M, Cozzi S, Tommasino C, et al: 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol 1997; 9:329-334 (Pubitemid 27465484)